浙江魅丽生物科技有限公司成立，注册资本2000万人民币

Company Overview - Zhejiang Meili Biotechnology Co., Ltd. was recently established with a registered capital of 20 million RMB [1][2] - The legal representative of the company is Zhou Jun [2] - The company is classified under the national standard industry of scientific research and technical services [2] Shareholding Structure - Hangzhou Huirun Enterprise Management Co., Ltd. holds a 90% stake in the company [1] - Zhejiang Heze Pharmaceutical Technology Co., Ltd. holds a 10% stake [1] Business Scope - The company’s business scope includes medical research and experimental development (excluding human stem cell and gene diagnosis and treatment technology development and application) [1] - It is involved in the development and application of human stem cell technology, sales and production of Class I and Class II medical devices, wholesale and retail of cosmetics, and sales of sanitary products and disposable medical supplies [1] - The company also engages in domestic trade agency, import and export of goods, and various technical services including consulting, development, and transfer [1] Licensing and Regulatory Compliance - The company is authorized to produce Class II medical devices and engage in the operation of Class III medical devices, as well as wholesale, production, and retail of pharmaceuticals, subject to approval from relevant authorities [1][2]